Slim Shady: Smugglers Eye Big Profits Running Weight Loss Drugs into Brazil

At dawn on a June morning, the bustling border town of Ciudad del Este in eastern Paraguay was alive with activity. Traders moved swiftly along its streets, exchanging goods ranging from household items to clothing. This city, located at the convergence of Paraguay, Brazil, and Argentina, sees over 100,000 people cross the Puente de Amistad (Friendship Bridge) daily from Brazil. While the bridge serves as a vital commercial artery, it has also become a focal point for illicit activities such as drug smuggling, human trafficking, and money laundering. Recently, a new lucrative opportunity has emerged for local smugglers, tirzepatide, a weight-loss medication primarily used to treat type 2 diabetes. According to seizure data, statements from smugglers, and reports from the pharmaceutical industry, the demand for tirzepatide has surged dramatically. In 2026 alone, Brazilian customs have already confiscated more than ten times the number of vials compared to the entire year of 2025. Earlier estimates by the Brazilian bank Itaú BBA placed the black-market value of the tirzepatide trade at approximately $485 million. Some Paraguayan law enforcement officials believe that Brazilian organized crime groups might be involved in the distribution of the drug, citing several major highway robberies targeting trucks transporting tirzepatide between March and July of this year. Local pharmacy owners are increasingly concerned due to the violence associated with the drug's trade. Gerardo Rivalora, a spokesperson for the regional association of pharmacies, expressed frustration with the lack of action from Paraguayan authorities. He emphasized the need for stronger measures against the escalating threat posed by the smuggling operations. Despite these concerns, representatives from Brazil's Federal Police, interviewed near the border city of Foz do Iguaçu, stated that they had not yet uncovered evidence linking organized crime groups to the tirzepatide trade, although incidents involving the theft of injectable slimming pens have occurred. Tirzepatide is legally produced in Paraguay, with a weekly dose costing roughly $40 based on online pharmacy listings. However, in Brazil, the drug is exclusively licensed by Eli Lilly, who markets it under the brand name Mounjaro. The cost of a weekly dose of Mounjaro in Brazil reaches up to $278, significantly higher than the price in Paraguay. This substantial price difference contributes to the high demand for the drug in the Brazilian black market. Brazil faces a rising obesity crisis, with one in four adults classified as obese, a trend projected to increase by 2030, according to the World Obesity Forum. This situation further fuels the demand for tirzepatide among consumers seeking affordable alternatives. Smuggling methods include "ant" networks, where individuals transport vials across the border hidden on their person, within vehicles, or even concealed in everyday items like food or cosmetics. Once inside Brazil, the drug is often transported via unrefrigerated trucks, which can compromise its effectiveness since it requires storage between 2 and 8 degrees Celsius. Alternatively, it moves through e-commerce platforms with minimal oversight of shipments. Officials from the Brazilian Federal Revenue Service in Foz do Iguaçu noted the challenges of monitoring the heavily trafficked border. They estimate that only 1 to 5 percent of all people and traffic crossing between the two countries can be inspected due to the sheer volume of movement. Carlos Dure, Commissioner of the Tripartite Command, a collaborative effort among the three nations' law enforcement agencies, reported that his team encounters nearly one major tirzepatide heist each week, alongside numerous smaller thefts and robberies affecting pharmacies. These incidents generate vast amounts of illicit income for criminals engaged in the trade.